Join @RimmPathology of Yale School of Medicine at #SABCS24 SABCS on Wednesday Dec. 11 from 7 to 8:30 AM CT as he moderates a session on “New Insights into Biomarkers.” #BreastCancer Yale Cancer Center

Happy to share our latest preprint from 1st author & Penn IGG PhD student Víctor R. Vázquez Marrero on how GM-CSF potentiates cytokine production in human monocytes during bacterial infection! Congrats to Victor, his undergrad mentees Allyson Lu & Madison Dresler, & postdoc Mikel Haggadone, PhD!

Abstract submissions close in about a month from today! Don't miss out on your chance to be a part of the FOCIS 2025 Annual Meeting. Deadline is January 15, 2025! Submit your abstract here: ow.ly/JrHl50UnL88

In ‘21 I left Harvard when my lab was growing quickly, I was an NIH Director DP5 Recipient, millions in grant funding and papers in top journals But pandemic put grants/publishing into new perspective Here’s a new interview covering *some* of why I left harvardmagazine.com/2025/01/harvar…

Thank you JEM for highlighting our work 🙏🙏🙏& congrats to first author @TimothyAWatkins and collaborators Yale School of Medicine

🌟 Join or Renew Your SMI Membership Today! 🌟 SMI membership is open to all immunologists, physicians, biochemists, dentists, veterinarians, and other scientists who conduct research in or who have an interest in mucosal immunology. Don’t miss out! socmucimm.org/membership-inf…

Check out this fantastic study by Ellen Foxman

We talked to the cofounder of Watch Duty, which has become an essential app in LA for tracking the wildfires: - It's a 501(c)(3) nonprofit largely supported by volunteers - Has had 100% uptime (and no mistaken evac notices vs the local gov sending THREE accidentally) - Over 1m

⁦silverman lab⁩ thanks so much for sharing your brilliance with us. Combined Peds and Lab medicine grand rounds. ⁦Yale Pediatrics⁩ ⁦Yale Lab Medicine⁩

Summary of RFK Hearings by ⁦⁩ Infectious Diseases Society of America & info for contacting elected representatives ⁦IDSA⁩ #id #vaccines idsociety.org/news--publicat…

1) Since there is a lot of confusion about the reduction of the overhead rate on NIH grants to 15% (see here: grants.nih.gov/grants/guide/n…) I'll do a little tweetorial (or X-torial?) about it.

The New York Times The Boston Globe The Washington Post

NIH indirect costs fund the backbone of research: maintaining labs, ensuring safety, and supporting admin work. These are essential for groundbreaking discoveries. Drastic cuts to NIH indirect rates are detrimental to academic biomedical research.

These great research institutions in red states are slated to lose about $1B in NIH research dollars

The indiscriminate and ill-conceived slashing of indirects by the NIH yesterday must be amended if want to restore America’s leadership role biomedical research. 15% simply isn’t enough for institutions to provide the basic infrastructure needed to run a successful lab. I say

More than 2/3 of new medicines are created by biotech and in-licensed by pharma, and nearly every innovative biotech comes from academia. That’s because it takes years and years of sustained and consistent focus and perseverance on a basic biological problem to lead to innovative

Watkins, Ellen Foxman et al. reveal that high burden of viruses and bacterial pathobionts drives heightened nasal innate immunity in children. hubs.la/Q036Gr_l0 📘 Host–Microbe Interactions 👉 hubs.la/Q036Gsg70 #KSHumanMicro25 #KSHostMicrobe25

"More than 99% of new drug approvals (2010-2019) were funded by NIH. Why dismantle the engine that made the U.S. a world leader in innovation and drug development ? #DoNotDefundScience jamanetwork.com/journals/jama-…